Patent Licensing: What Founders Need to Know Before Signing Anything

A patent gives you the right to exclude others from practicing your invention — but that right is only valuable if you can enforce it or monetize it. Licensing is how most patent owners turn that right into revenue, and how most companies avoid litigation when they need to use someone else's technology. Understanding the basic mechanics before you're at the table saves you from agreeing to terms you can't undo.

What a Patent License Actually Is

A patent license is a contract in which the patent owner (the licensor) gives another party (the licensee) permission to do something that would otherwise infringe the patent. Without a license, making, using, selling, offering for sale, or importing a patented invention in the United States is infringement. With a license, that same activity is authorized — but only to the extent the license allows.

Two distinctions matter immediately:

• Exclusive vs. non-exclusive. An exclusive license means only the licensee can practice the patent in the defined scope. The patent owner typically cannot even use it themselves in that scope unless they reserve the right explicitly. A non-exclusive license is a permission slip — the owner can hand out as many as they want.
• Field-of-use and territory restrictions. Licenses are almost always limited. A license might cover only a specific industry, geography, product line, or application. Operating outside those limits is infringement, even if you hold a license for something adjacent.

The Terms That Move the Money

Licensing deals are structured in a handful of standard ways, and the financial terms define the real value of what you're getting or giving up.

Royalties

A running royalty ties payment to actual use — typically a percentage of net sales or a fixed dollar amount per unit. This is common in patent licensing because it aligns payment with commercialization. Watch carefully how "net sales" is defined; deductions for returns, taxes, and shipping can shrink the base significantly.

Lump-Sum Payments

Some licenses are paid out in full upfront. This transfers risk: if the product underperforms, the licensor already has their money; if it overperforms, the licensee keeps the upside.

Milestone Payments

Common in life sciences and early-stage tech deals, these are fixed payments triggered by events — regulatory approval, first commercial sale, hitting a revenue threshold. They're predictable for planning but require careful drafting of what each trigger actually means.

Minimum Royalties

A non-exclusive licensee might agree to pay a minimum annual amount regardless of actual sales. This protects the licensor from a licensee who sits on rights and blocks others from licensing. If you're the licensee, minimums commit you to real money even if the product doesn't ship.

What Gets Negotiated Beyond Money

Financial terms get attention, but several non-financial provisions can matter just as much.

Sublicensing Rights

Can you sublicense the patent to a partner, manufacturer, or acquirer? Without explicit permission, you generally cannot. If your business model depends on sublicensing — or if you plan to be acquired — this needs to be addressed before you sign.

Improvement Clauses and Grant-Backs

Some licenses require the licensee to license improvements back to the original licensor, sometimes exclusively. This can effectively transfer the value of your own R&D to someone else. Read these provisions closely.

Enforcement Obligations

Who is responsible for policing infringers? In an exclusive license, the licensee often has standing to sue — but only if the agreement grants it clearly. A licensor with no enforcement obligation and a licensee with no standing can leave a patent undefended against infringers who undercut the entire deal.

Termination Triggers

Licenses typically terminate for breach, bankruptcy, or failure to meet milestones. If you're the licensee, losing the license mid-product-cycle can be existential. Cure periods, notice requirements, and dispute resolution mechanisms all determine how much runway you actually have.

Practical Takeaways

• Exclusive licenses transfer significant value — if you're granting one, understand that you may be giving up your own ability to practice the patent in that scope.
• Always define the licensed scope precisely: field of use, geography, product category, and patent claims covered all need to be spelled out.
• "Net sales" and royalty base definitions are negotiating points, not boilerplate — small differences compound over a long license term.
• Sublicensing rights, grant-backs, and enforcement standing have strategic consequences that often outweigh royalty rate differences.
• Minimum royalty commitments are real financial obligations; model them against your actual commercialization timeline before agreeing.
• Patent licenses touch on antitrust, contract, and patent law simultaneously — have counsel review any agreement before you sign, not after.

This guide is general education, not legal advice, and does not create an attorney–client relationship. For your specific situation, talk to a registered patent attorney.